$473 Million Worldwide Aseptic Sampling Industry to 2025 - Featuring Danaher, Saint-Gobain & GEA Group Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Aseptic Sampling Market by Type (Manual [Type (Traditional, Single-use), Product (Bags, Bottles, Syringes, Accessories)], Automatic), Application (Upstream, Downstream), Technique (Off-line, On-line), End User (R&D, CMO, CRO) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global aseptic sampling market is projected to reach USD 473.8 million by 2025 from USD 263.9 million in 2020, at a CAGR of 12.4% during the forecast period.

The growth of this market is driven majorly by factors such as the increasing demand for biopharmaceuticals, stringent government regulations to ensure drug safety, and funding to support life sciences research activities. On the other hand, issues related to leachables and extractable from single-use products are restraining market growth.

By type, the manual aseptic sampling segment is expected to grow at the highest CAGR during the forecast period.

Based on type, the aseptic sampling market is segmented into manual aseptic sampling and automated aseptic sampling. The manual aseptic segment is expected to register the highest growth during the forecast period. Manual aseptic sampling has traditionally been used in pharmaceutical and biotechnology manufacturing. Also, manufacturers are reluctant to shift to automatic sampling, citing high costs and the need to train staff to handle automated sampling processes.

By end-user, the biotechnology and pharmaceutical manufacturers segment dominated the aseptic sampling market in 2019.

Based on end-user, the aseptic sampling market is segmented into biotechnology and pharmaceutical manufacturers, contract research and manufacturing organizations, R&D departments, and other end users. The biotechnology and pharmaceutical manufacturers segment accounted for the largest share of the aseptic sampling market in 2019, primarily due to the increasing adoption of aseptic sampling in existing manufacturing facilities owing to advantages such as low capital cost and easy implementation.

Asia Pacific aseptic sampling market is expected to witness the highest growth during the forecast period.

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period, primarily due to the expanding biomanufacturing sector, increasing government support, developing R&D infrastructure, and the growing outsourcing of bioproduction processes to this region from North America and Europe.

Market Dynamics

Drivers

• Increasing Demand for Biopharmaceuticals
• Advantages of Single-Use Aseptic Sampling Systems in Improving Process Efficiency and Reducing the Risk of Product Cross-Contamination
• Stringent Government Regulations for Ensuring Drug Safety
• Funding to Support Life Science Research Activities

Restraints

• Issues Related to Leachables and Extractables

Opportunities

• Increased Risk of Pandemics and Communicable Diseases
• Emerging Markets to Offer Lucrative Growth Opportunities
• Patent Expiry of Major Drugs

Challenges

• Waste Disposal
• Slow Adoption of Advanced Technologies in Biopharmaceutical Manufacturing
• Slowdown in R&D Activities Due to the Covid-19 Pandemic
  

Companies Profiled

• Merck Kgaa
• Sartorius Stedim Biotech
• Thermo Fisher Scientific
• Danaher Corporation
• Saint-Gobain
• GEA Group
• Qualitru Sampling Systems
• Keofitt
• Gem Group
• W. L. Gore & Associates
• Flownamics Analytical Instruments
• Lonza
• Trace Analytics
• VWR International, Llc. (Avantor, Inc.)
• Bbi-Biotech Gmbh
• Advanced Microdevices Pvt. Ltd.
• Deltalab
• Other Companies
• MTC Bio
• Biomatics Technology
• Labplas
  

For more information about this report visit https://www.researchandmarkets.com/r/rld411